Petrikkos G, Tsioutis C. Recent advances in the pathogenesis of mucormycoses. Clin Ther. 2018;40(6):894–902. https://doi.org/10.1016/j.clinthera.2018.03.009.

Article  CAS  PubMed  Google Scholar 

Zaman K, Rudramurthy SM, Das A, Panda N, Honnavar P, Kaur H, et al. Molecular diagnosis of rhino-orbito-cerebral mucormycosis from fresh tissue samples. J Med Microbiol. 2017;66(8):1124–9. https://doi.org/10.1099/jmm.0.000560.

Article  CAS  PubMed  Google Scholar 

Richardson M. The ecology of the Zygomycetes and its impact on environmental exposure. Clin Microbiol Infect. 2009;15(Suppl. 5):2–9. https://doi.org/10.1111/j.1469-0691.2009.02972.x.

Article  PubMed  Google Scholar 

Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13(2):236–301. https://doi.org/10.1128/CMR.13.2.236.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53. https://doi.org/10.1086/432579.

Article  PubMed  Google Scholar 

Roilides E, Antachopoulos C, Simitsopoulou M. Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs. Mycoses. 2014;57(s3):40–7. https://doi.org/10.1111/myc.12236.

Article  CAS  PubMed  Google Scholar 

Netea MG, Van der Meer JWM, Kullberg B-J. Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence. Clin Microbiol Infect. 2006;12(5):404–9. https://doi.org/10.1111/j.1469-0691.2006.01388.x.

Article  CAS  PubMed  Google Scholar 

Gebremariam T, Liu M, Luo G, Bruno V, Phan QT, Waring AJ, et al. CotH3 mediates fungal invasion of host cells during mucormycosis. J Clin Invest. 2014;124(1):237–50. https://doi.org/10.1172/JCI71349.

Article  CAS  PubMed  Google Scholar 

Prakash H, Ghosh AK, Rudramurthy SM, Singh P, Xess I, Savio J, et al. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment. Med Mycol. 2019;57(4):395–402. https://doi.org/10.1093/mmy/myy060.

Article  PubMed  Google Scholar 

Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47(4):503–9. https://doi.org/10.1086/590004.

Article  PubMed  Google Scholar 

Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26–34. https://doi.org/10.1016/j.cmi.2018.07.011.

Article  CAS  PubMed  Google Scholar 

Prakash H, Chakrabarti A. Epidemiology of Mucormycosis in India. Microorganisms. 2021;9(3):523. https://doi.org/10.3390/microorganisms9030523.

Article  PubMed  PubMed Central  Google Scholar 

Prattes J, Wauters J, Giacobbe D, Lagrou K, Hoenigl M, Koehler P, et al. Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive Care Med. 2021;47(10):1158–60. https://doi.org/10.1007/s00134-021-06471-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

IDF Diabetes Atlas. Demographic and geographic outline. Available from: https://www.diabetesatlas.org/en/sections/demographic-and-geographic-outline.html.

Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia. 2020;185(4):599–606. https://doi.org/10.1007/s11046-020-00462-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405–21. https://doi.org/10.1016/S1473-3099(19)30312-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spallone A, Moran C, Wurster S, Axell-House D, Kontoyiannis D. Taking a closer look: clinical and histopathological characteristics of culture-positive versus culture-negative pulmonary mucormycosis. J Fungi. 2022;8(4):380. https://doi.org/10.3390/jof8040380.

Article  Google Scholar 

Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021;15(4):102146. https://doi.org/10.1016/j.dsx.2021.05.019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi. 2021;7(4):298. https://doi.org/10.3390/jof7040298.

Article  CAS  Google Scholar 

Ahmadikia K, Hashemi SJ, Khodavaisy S, Getso MI, Alijani N, Badali H, et al. The double-edged sword of systemic corticosteroid therapy in viral pneumonia: a case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis. Mycoses. 2021;64(8):798–808. https://doi.org/10.1111/myc.13256.

Smith HW, Kirchner JA. Cerebral mucormycosis: a report of three cases. AMA Arch Otolaryngol. 1958;68(6):715–26. https://doi.org/10.1001/archotol.1958.00730020739010.

Article  CAS  PubMed  Google Scholar 

Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl. 1):S23–34. https://doi.org/10.1093/cid/cir866.

Article  PubMed  Google Scholar 

Sugar AM. Mucormycosis. Clin Infect Dis. 1992;14(Suppl. 1):S126–9. http://www.jstor.org/stable/4456403.

PubMed  Google Scholar 

Klimko NN, Khostelidi SN, Volkova AG, Popova MO, Bogomolova TS, Zuborovskaya LS, et al. Mucormycosis in haematological patients: case report and results of prospective study in Saint Petersburg, Russia. Mycoses. 2014;57(s3):91–6. https://doi.org/10.1111/myc.12247.

Article  PubMed  Google Scholar 

Vehreschild JJ, Koehler P, Lamoth F, Prattes J, Rieger C, Rijnders BJA, et al. Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patients. Med Mycol. 2021;59(1):93–101. https://doi.org/10.1093/mmy/myaa079.

Article  CAS  PubMed  Google Scholar 

Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018;56(Suppl. 1):S93–101. https://doi.org/10.1093/mmy/myx101.

Article  CAS  PubMed Central  Google Scholar 

Rana N. COVID-19 Associated rhino-orbital-cerebral mucormycosis - an institutional series. J Clin Otorhinolaryngol. 2022;4(1):1–9. https://doi.org/10.31579/2692-9562/041.

Article  Google Scholar 

Sanguinetti M, Posteraro B, Beigelman-Aubry C, Lamoth F, Dunet V, Slavin M, et al. Diagnosis and treatment of invasive fungal infections: looking ahead. J Antimicrob Chemother. 2019;74(Suppl. 2):ii27–37. https://doi.org/10.1093/jac/dkz041.

Article  CAS  PubMed  Google Scholar 

Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (Zygomycosis). Clin Infect Dis. 2012;54(Suppl. 1):S55–60. https://doi.org/10.1093/cid/cir868.

Article  PubMed  Google Scholar 

Aggarwal D, Chander J, Janmeja AK, Katyal R. Pulmonary tuberculosis and mucormycosis co-infection in a diabetic patient. Lung India. 2015;32(1):53–5. https://doi.org/10.4103/0970-2113.148452.

Article  PubMed  PubMed Central  Google Scholar 

Peterson KL, Wang M, Canalis RF, Abemayor E. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope. 1997;107(7):855–62. https://doi.org/10.1097/00005537-199707000-00004.

Article  CAS  PubMed  Google Scholar 

Legouge C, Caillot D, Chrétien M-L, Lafon I, Ferrant E, Audia S, et al. The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia? Clin Infect Dis. 2014;58(5):672–8. https://doi.org/10.1093/cid/cit929.

Article  CAS  PubMed  Google Scholar 

Patterson TF, Thompson GR III, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1–60. https://doi.org/10.1093/cid/ciw326.

Article  PubMed  PubMed Central  Google Scholar 

Millon L, Herbrecht R, Grenouillet F, Morio F, Alanio A, Letscher-Bru V, et al. Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF). Clin Microbiol Infect. 2016;22(9):810.e1–8. https://doi.org/10.1016/j.cmi.2015.12.006.

Article  CAS  Google Scholar 

Dadwal SS, Kontoyiannis DP. Recent advances in the molecular diagnosis of mucormycosis. Expert Rev Mol Diagn. 2018;18(10):845–54. https://doi.org/10.1080/14737159.2018.1522250.

Article  CAS  PubMed  Google Scholar 

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl. 1):e1–38. https://doi.org/10.1016/j.cmi.2018.01.002.

Article  PubMed  Google Scholar 

Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica. 2017;102(3):433–44. https://doi.org/10.3324/haematol.2016.152900.

Article  PubMed  PubMed Central